Flavius Şandra-Petrescu

Dr. Flavius Şandra-Petrescu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
FŞFlavius Şandra-Petrescu
Flavius Şandra-Petrescu
FHFlorian Herrle
Florian Herrle
AHAxel Hinke
Axel Hinke
IRInga Rossion
Inga Rossion
HSHeiko Suelberg
Heiko Suelberg
PKPeter Kienle
Peter Kienle
Current evidence supports a diverting stoma in patients undergoing low anterior resection with total mesorectal excision for rectal cancer as it reduces clinical severity of anastomotic leakage. However, relevant stoma morbidity after rectal cancer surgery exists and has a significant impact on quality of life. Moreover, a diverting stoma has an influence on completeness of chemotherapy but it remains unclear in which way. There is no evidence regarding optimal timing for stoma closure in relation to adjuvant chemotherapy. Two randomised controlled trials have studied early stoma closure after low anterior resection in patients with rectal cancer, one of them showing that early closure around day 8 after resection is possible without increasing morbidity. CoCStom is a randomised multicentre trial comparing completeness of adjuvant chemotherapy as primary endpoint after early (8–10 days after resection, before starting adjuvant therapy) versus late (~26 weeks after resection and completion of adjuvant therapy) stoma closure in patients with locally advanced rectal cancer undergoing low anterior resection after neoadjuvant therapy. After exclusion of post-operative anastomotic leakage 257 patients from 30 German hospitals are planned to be included in order to assure a power of 80 % for the confirmatory analysis of at least 214 evaluable cases. An absolute increase of 20 % for the rate of completely administered adjuvant chemotherapy is regarded as a clinically meaningful step forward and serves as basis for sample size calculation. Quality of life, stoma-related complications, individual completeness of chemotherapy rate, percentage of patients stopping adjuvant therapy or undergoing dose modifications or delay, oncological outcomes, cumulative days of hospitalisation and number of readmissions, rate of symptomatic anastomotic leaks after stoma closure, mortality, post-operative complications and toxicity of adjuvant chemotherapy are secondary endpoints. The CoCStom trial aims to clarify optimal timing of stoma closure in the context of adjuvant chemotherapy. Depending on the results of the trial, patients could benefit either from early or late stoma closure in regard to long term oncological survival due to a higher rate of completeness of adjuvant chemotherapy treatment and thus better effectiveness. German Clinical Trials Register, DRKS00005113 . Registered 28 August 2013

28 August 2021 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
FŞFlavius Şandra-Petrescu
Flavius Şandra-Petrescu
ETEmmanouil Tzatzarakis
Emmanouil Tzatzarakis
GKGeorg Kähler
Georg Kähler
Christoph ReissfelderChristoph Reissfelder
Christoph Reissfelder
FHFlorian Herrle
Florian Herrle
Purpose: Management of colorectal anastomotic leakage (AL) is patient-oriented and requires an interdisciplinary approach. We analyzed the management of AL according to its severity and presence of ostomy and proposed a therapy algorithm. Methods: We identified all patients who underwent colorectal surgery and developed an AL in our clinic between 2012 and 2017. The management of AL was retrospectively analyzed according to the severity grade: asymptomatic (A), requesting interventional or antibiotic therapy (B), undergoing re-operation (C). The groups were compared according to the leakage characteristics, presence of ostomy, and patient clinical conditions. Results: We identified 784 consecutive patients meeting the inclusion criteria. Of these, 10.8% experienced an AL (A = 18%, B = 48%, and C = 34%). The rate of successful ostomy closure was 100% (A), 68% (B), and 62% (C), respectively. Within group B, 91% of the patients were treated solely by endoscopic negative pressure therapy (ENPT), whereas 37% of the patients within group C required ENPT in addition to surgery. Seven cases within group B (17%) required no protective ostomy (nOB) during ENPT which was itself shorter and required less cycles in comparison to group B with ostomy (OB) (p = 0.017 and 0.111, respectively). Moreover, the leakage distance to anal verge was higher in the OB subgroup (p < 0.001). Conclusion: ENPT for the treatment of colorectal AL is efficient in combination with operative revision or protective ostomy. In selected patients, it is feasible also in the absence of a protective ostomy.

1 July 2015 in Human Immunology
Verified
Journal Article
Closed access
LDLaura Dittmar
Laura Dittmar
EMElisabeth Mohr
Elisabeth Mohr
CKChristian Kleist
Christian Kleist
SESandra Ehser
Sandra Ehser
HDHaydar Demirdizen
Haydar Demirdizen
PTPeter Terness
Peter Terness

2 August 2022 in Pancreatology
Verified
Journal Article
Closed access
FŞFlavius Şandra-Petrescu
Flavius Şandra-Petrescu
ETEmmanouil Tzatzarakis
Emmanouil Tzatzarakis
MBMamdouh Mansour Basha
Mamdouh Mansour Basha
FRFelix Rückert
Felix Rückert
Christoph ReissfelderChristoph Reissfelder
Christoph Reissfelder
NRNuh N. Rahbari
Nuh N. Rahbari

Verified
Journal Article
Open access
PDF file
FŞFlavius Şandra-Petrescu
Flavius Şandra-Petrescu
NRNuh N. Rahbari
Nuh N. Rahbari
EBEmrullah Birgin
Emrullah Birgin
KKKonstantinos Kouladouros
Konstantinos Kouladouros
PKPeter Kienle
Peter Kienle
FHFlorian Herrle
Florian Herrle
(1) Background: A widely accepted algorithm for the management of colorectal anastomotic leakage (CAL) is difficult to establish. The present study aimed to evaluate the current clinical practice on the management of CAL among the German CHIR-Net centers. (2) Methods: An online survey of 38 questions was prepared using the International Study Group of Rectal Cancer (ISREC) grading score of CAL combined with both patient- and surgery-related factors. All CHIR-Net centers received a link to the online questionary in February 2020. (3) Results: Most of the answering centers (55%) were academic hospitals (41%). Only half of them use the ISREC definition and grading for the management of CAL. A preference towards grade B management (no surgical intervention) of CAL was observed in both young and fit as well as elderly and/or frail patients with deviating ostomy and non-ischemic anastomosis. Elderly and/or frail patients without fecal diversion are generally treated as grade C leakage (surgical intervention). A grade C management of CAL is preferred in case of ischemic bowel, irrespective of the presence of an ostomy. Within grade C management, the intestinal continuity is preserved in a subgroup of patients with non-ischemic bowel, with or without ostomy, or young and fit patients with ischemic bowel under ostomy protection. (4) Conclusions: There is no generally accepted therapy algorithm for CAL management within CHIR-Net Centers in Germany. Further effort should be made to increase the application of the ISREC definition and grading of CAL in clinical practice.

28 March 2025 in Annals of Surgery
Verified
Journal Article
Open access
FHFlorian Herrle
Florian Herrle
FŞFlavius Şandra-Petrescu
Flavius Şandra-Petrescu
SRSimone Rothenhoefer
Simone Rothenhoefer
JHJulia Hardt
Julia Hardt
SSSteffen Seyfried
Steffen Seyfried
PKPeter Kienle
Peter Kienle
Objective: The DELORES trial investigated whether laparoscopic resection rectopexy (LRR) is superior to Delorme’s procedure (DP) in full-thickness rectal prolapse. Background: Multiple perineal and transabdominal procedures are current practice for rectal prolapse surgery. Evidence from adequately designed randomized studies addressing the question of which of these procedures are superior in terms of recurrence and bowel function is lacking. Methods: DELORES was a randomized, observer-blinded, expertise-based multicenter trial. Patients with full-thickness rectal prolapse were eligible. The primary outcome was time to recurrence of full-thickness rectal prolapse within 24 months after primary surgery. The main secondary endpoints were morbidity, hospital stay, quality of life, constipation, and fecal incontinence (DRKS00000482). Results: A total of 358 patients were screened between September 2010 and January 2016. Based on screening, 70 patients were randomized and 65 were included in the analysis (33 LRR and 32 DP procedures). The median follow-up was 23.9 months. Analysis of the primary outcome showed that LRR was superior to DP ( P =0.0012). During the 24-month follow-up, 8.2% of patients in the LRR group had a full-thickness prolapse recurrence versus 42.8% in the DP group. The median time to recurrence was 17.8 months for LRR and 8.2 months for DP. The median duration of surgery was 212 min (LRR) versus 77 min (DP). Overall postoperative morbidity was low. The reoperation rate was higher for DP (0% LRR vs. 33.3% DP). Quality of life (FIQL) and incontinence scores (Wexner) were more favorable for LRR at 24-month follow-up. Conclusions: LRR is superior to DP in terms of recurrence and has favorable functional results.